Gene Therapy
Key Statistics
Client
bluebird bio
PM Group Office
Boston
Cost
Confidential
Size
53,000sqft

bluebird bio is a clinical-stage company that develops potentially transformative therapies with product platforms including gene therapy, cancer immunotherapy and gene editing. PM Group has worked with bluebird bio since 2015, providing high level Subject Matter Expert (SME) support, as well as engineering design services.

Do you have a pharmaceutical project? Talk to one of our experts.

Andy Rayner
Andy Rayner

Pharmaceutical Sector Director

Viral vector manufacturing facility

PM Group recently completed the schematic design for a 53,000sqft world-class viral vector manufacturing facility in Durham, NC. The project has a fast track schedule - construction started in February 2018 and manufacturing is due to begin in Q2 2019. Our team is providing process engineering design which includes P&IDs, equipment specification, procurement support, process simulation and modeling for production planning.

 

Technologies on this Project include: 

  • Single use technologies (bioreactors and purification) for viral vector preparation 
  • Filling line and isolator 
  • BSL-2 level of containment 
Andy Rayner

Pharmaceutical Sector Director